Skip to main content

Table 2 Univariate comparison of the baseline characteristics of C. difficile infections caused by C. difficile strains of ribotype 001, ribotype 176, binary toxin genes carrying and showing the reduced susceptibility to moxifloxacin

From: The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients

  Ribotype 001 Ribotype 176 Binary toxin genes Moxifloxacin (RS)
p-value Adjusted p-value p-value Adjusted p-value p-value Adjusted p-value p-value Adjusted p-value
Age 0.00 0.02 0.30 1.00 0.24 1.00 0.00 0.00
Gender 0.16 0.95 0.02 0.18 0.03 0.23 0.39 1.00
HA CDI origin 0.03 0.23 1.00 1.00 0.96 1.00 0.02 0.22
Recurrent CDI 0.35 1.00 0.09 0.61 0.26 1.00 0.35 1.00
Complicated CDI 0.27 1.00 0.12 0.86 0.90 1.00 0.93 1.00
30-days mortality 0.10 0.40 0.40 1.00 0.94 1.00 0.01 0.04
All-cause mortality 0.00 0.01 0.67 1.00 0.87 1.00 0.00 0.00
  1. CDI Clostridium difficile infection, CI confidential interval, HA healthcare-associated, RS reduced susceptibility